AbbVie’s Skyrizi took home the top spot for most pharma brand ad impressions in April 2025, according to data released by ...

AbbVie snagged yet another spot among April’s highest TV ad spenders, as its Vraylar jumped two spots to eighth place with a ...

Pharma giant AbbVie has been taken to task by the FDA for running an ad for one of its migraine drugs, featuring tennis star Serena Williams, which the agency says overstates its efficacy.

AbbVie is poised to grow this year for the first ... Kennedy has floated the idea of banning pharmaceutical companies from placing TV ads in the United States. It sounds scary, but pharmaceutical ...

We recently published a list of the 15 Best Dividend Stocks to Buy for Long-Term Passive Income. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best ...

AbbVie Inc. ABBV, a biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company's stock traded at ...

An AbbVie research and development lab in San Francisco. (Brian L. Frank for The Wall Street Journal) Drugmaker AbbVie plans to invest more than $10 billion in domestic manufacturing and other ...

Advertisement Article continues below this ad The drugmaker posted revenue of $13.34 billion in the period, which also beat Street forecasts. Seven analysts surveyed by Zacks expected $12.91 billion.